Particle.news

Download on the App Store

Trump Signs HALT Fentanyl Act to Permanently Schedule All Analogs as Schedule I

It imposes a 10-year mandatory minimum for traffickers, closes molecular-structure loopholes and creates a unified registration process for fentanyl research.

Image
Image
U.S President Donald Trump speaks before signing the HALT Fentanyl Act, in the East Room at the White House in Washington, D.C., U.S., July 16, 2025. REUTERS/Nathan Howard
U.S President Donald Trump holds the HALT Fentanyl Act after signing, in the East Room at the White House in Washington, D.C., U.S., July 16, 2025. REUTERS/Nathan Howard

Overview

  • President Trump signed the HALT Fentanyl Act on July 16 at the White House with bipartisan lawmakers and families of overdose victims in attendance.
  • The law makes permanent the Schedule I classification for all fentanyl-related substances to prevent chemists from evading federal controls by tweaking molecular structures.
  • It mandates a minimum 10-year prison sentence for anyone who possesses, imports, distributes or manufactures illicit fentanyl analogs and strengthens federal enforcement authority.
  • Researchers will benefit from streamlined DEA registration rules, including single-site credentials, waived inspections in certain cases and limited small-quantity manufacturing without extra licensing.
  • The legislation follows overwhelming congressional votes and complements broader efforts such as tariffs on precursor-supplying nations and enhanced border deployments to disrupt the fentanyl supply chain.